Previous 10 | Next 10 |
Background: I am an orthopedic surgeon in a busy practice. I have used Flexion's (FLXN) knee arthritis product Zilretta clinically, and I have met with the sales representative from Flexion on three occasions. I have performed approximately 20 Zilretta injections. I do not think the proponents...
Image source: The Motley Fool. Smith & Nephew plc (NYSE: SNN) Q2 2020 Earnings Call Jul 29, 2020 , 3:30 a.m. ET Operator Continue reading
Smith & Nephew plc (SNN) Q2 2020 Earnings Conference Call July 29, 2020 03:30 AM ET Company Participants Roland Diggelmann - CEO Ian Melling - Interim Chief Financial Officer Conference Call Participants Patrick Wood - Bank of America Merrill Lynch Kit Lee - Jefferies I...
The following slide deck was published by Smith & Nephew plc in conjunction with their 2020 Q2 earnings Read more ...
Smith & Nephew (NYSE: SNN ) : 1H Non-GAAP EPS of $0.13; GAAP EPS of $0.12. More news on: Smith & Nephew plc, Earnings news and commentary, Healthcare stocks news, Read more ...
LONDON , July 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of the RI.HIP NAVIGATION for total hip arthroplasty (THA). This new technology is designed to help maximize accuracy and...
LONDON , July 14, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its new generation handheld robotics platform - the CORI Surgical System. ...
The global pandemic has devastated orthopedic companies that manufacture hip, knee, shoulder, and dental replacements. The elective surgeries that use these healthcare products have mostly been put on hold during the COVID-19 pandemic. Shares in Smith+Nephew (NYSE: SNN) , Zimmer Biomet ...
LONDON , June 18, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that over two million patients have been treated with implants made from OXINIUM Technology - a proprietary oxidized zirconium alloy used in hip and knee replace...
LONDON , June 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announced that its REGENETEN Bioinductive Implant has successfully received CE Mark certification allowing the implant to now be used and sold in key European mark...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...